--- title: "Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket" type: "News" locale: "en" url: "https://longbridge.com/en/news/299420314.md" description: "Alaunos Therapeutics shares surged 21.8% in pre-market trading after adopting amended bylaws. Other gainers included Cheetah Net (+77.8%) and Delixy Holdings (+34.9%). Conversely, Xenon Pharmaceuticals dropped 27.6% following a pause in study enrollment, while Datasea Intelligent Technology fell 16.4% despite recent AI partnership announcements." datetime: "2026-09-18T08:25:11.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/299420314.md) - [en](https://longbridge.com/en/news/299420314.md) - [zh-HK](https://longbridge.com/zh-HK/news/299420314.md) generator: "portal-rs" --- # Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket Shares of **Alaunos Therapeutics Inc** (NASDAQ:TCRT) rose sharply in pre-market trading following a Securities and Exchange Commission filing that showed the company approved and adopted its Second Amended and Restated By-Laws, effective immediately. According to the filing, the adoption happened on Wednesday. Alaunos Therapeutics shares jumped 21.8% to $1.95 in pre-market trading. Here are some other stocks moving in pre-market trading. ### Gainers - **Cheetah Net Supply Chain Service Inc** (NASDAQ:CTNT) gained 77.8% to $0.080 in pre-market trading after rising 8% on Thursday. - **Delixy Holdings Ltd** (NASDAQ:DLXY) rose 34.9% to $1.14 in pre-market trading after dipping around 63% on Thursday. Delixy Holdings recently announced it entered into a non-binding letter of intent with Caog for acquisition or merger of up to 48% of shares in Tarbagatay Munay. - **Generation Income Properties Inc** (NASDAQ:GIPR) rose 29.5% to $0.57 in pre-market trading after gaining over 20% on Thursday. - **Pop Culture Group Co Ltd** (NASDAQ:CPOP) rose 22.8% to $4.57 in pre-market trading after surging 20% on Thursday. Pop Culture Group recently announced a 15-for-1 stock split. - **BTC Digital Ltd** (NASDAQ:BTCT) rose 12.9% to $1.31 in pre-market trading after gaining around 3% on Thursday. - **Amaze Holdings Inc** (NYSE:AMZE) gained 11.7% to $0.16 in pre-market trading after rising 8% on Thursday. The company announced the launch of a new subscription model. - **Securitize Corp** (NYSE:SECZ) rose 8.6% to $9.70 in pre-market trading after surging around 10% on Thursday. - **908 Devices In**c (NASDAQ:MASS) gained 7.7% to $11.83 in pre-market trading after jumping over 10% on Thursday. - **Cybin Inc** (NASDAQ:HELP) rose 6.3% to $14.90 in pre-market trading following a 4% gain on Thursday. ### Losers - **Xenon Pharmaceuticals Inc** (NASDAQ:XENE) tumbled 27.6% to $41.51 in pre-market trading after the company announced a temporary pause in enrollment for new patients in its ongoing psychiatry studies. - **Datasea Intelligent Technology Lt**d (NASDAQ:DTSS) fell 16.4% to $1.02 in pre-market trading. Datasea Intelligent Technology shares jumped 106% on Thursday after the company announced its Chinese operating entities have recently entered into AI agent digital marketing service cooperation agreements and pre-order arrangements with five customers. - **Firefly Neuroscience Inc** (NASDAQ:AIFF) fell 14.1% to $1.10 in pre-market trading. Firefly Neuroscience shares jumped around 38% on Thursday after the company announced a strategic collaboration with Radial to pursue integration of AI-powered Evoke EEG/ERP platform with RadialOS. - **Abits Group Inc** (NASDAQ:ABTS) fell 13.5% to $1.23 in pre-market trading. - **RenX Enterprises Corp** (NASDAQ:RENX) declined 13.3% to $1.37 in pre-market trading. - **AGM Group Holdings Inc** (NASDAQ:AGMH) fell 12.6% to $0.73 in pre-market trading after gaining 32% on Thursday. - **Wheeler Real Estate Investment Trust Inc** (NASDAQ:WHLR) fell 11.2% to $0.33 in pre-market trading after the company announced a 1-for-9 reverse stock split. - **Frontline Plc** (NYSE:FRO) fell 6.4% to $50.65 in pre-market trading. - **Biohaven Ltd** (NYSE:BHVN) fell 6.4% to $13.00 in pre-market trading after jumping over 15% on Thursday. - **Nucor Corp** (NYSE:NUE) fell 3.1% to $257.00 in pre-market trading. Nucor said it sees third-quarter earnings of $5.55 to $5.65 per diluted share, up from $2.63 per share in the year-ago quarter. *Photo via Shutterstock* ### Related Stocks - [DTSS.US](https://longbridge.com/en/quote/DTSS.US.md) - [CTNT.US](https://longbridge.com/en/quote/CTNT.US.md) - [DLXY.US](https://longbridge.com/en/quote/DLXY.US.md) - [XENE.US](https://longbridge.com/en/quote/XENE.US.md) - [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md) - [GIPR.US](https://longbridge.com/en/quote/GIPR.US.md) - [CPOP.US](https://longbridge.com/en/quote/CPOP.US.md) - [BTCT.US](https://longbridge.com/en/quote/BTCT.US.md) - [AMZE.US](https://longbridge.com/en/quote/AMZE.US.md) - [SECZ.US](https://longbridge.com/en/quote/SECZ.US.md) - [MASS.US](https://longbridge.com/en/quote/MASS.US.md) - [HELP.US](https://longbridge.com/en/quote/HELP.US.md) - [AIFF.US](https://longbridge.com/en/quote/AIFF.US.md) - [ABTS.US](https://longbridge.com/en/quote/ABTS.US.md) - [RENX.US](https://longbridge.com/en/quote/RENX.US.md) - [AGMH.US](https://longbridge.com/en/quote/AGMH.US.md) - [WHLR.US](https://longbridge.com/en/quote/WHLR.US.md) - [FRO.US](https://longbridge.com/en/quote/FRO.US.md) - [BHVN.US](https://longbridge.com/en/quote/BHVN.US.md) - [NUE.US](https://longbridge.com/en/quote/NUE.US.md) - [GIPRW.US](https://longbridge.com/en/quote/GIPRW.US.md) - [BTCTW.US](https://longbridge.com/en/quote/BTCTW.US.md) - [CYBN.US](https://longbridge.com/en/quote/CYBN.US.md) - [WHLRP.US](https://longbridge.com/en/quote/WHLRP.US.md) - [WHLRL.US](https://longbridge.com/en/quote/WHLRL.US.md) - [WHLRD.US](https://longbridge.com/en/quote/WHLRD.US.md) ## Related News & Research - [Alaunos Therapeutics Enters Securities Purchase Agreement With Accredited Investors](https://longbridge.com/en/news/299810727.md) - [Xenon Files Azetukalner NDA as It Pauses Psychiatry Trials for Tolerability Review](https://longbridge.com/en/news/300225771.md) - [Alaunos Therapeutics Announces New Registered Direct Offering](https://longbridge.com/en/news/299813835.md) - [Xenon Pharmaceuticals Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Xenon Pharmaceuticals (XENE)](https://longbridge.com/en/news/299818011.md) - [Xenon Pharmaceuticals (XENE) Could Be 47% Undervalued Following Psychiatry Trial Pause](https://longbridge.com/en/news/299566976.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**